从人听闻到可行的:复杂的公共卫生干预措施的定性评估工具
Celeste Nicholas1, Tess D Weathers1, Lisa K Staten1
1Indiana University, Indianapolis, IN, USA.
Health promotion practice
|November 26, 2024
概括
公共卫生干预是复杂的. 定性FIND (框架,识别,缩小,做) 过程为评估复杂的,社区参与的健康公平倡议提供了实际指导,改善了数据驱动的决策.
科学领域:
- 公共卫生 公共卫生
- 健康 公平 卫生 公平
- 项目评价 项目评估
背景情况:
- 公共卫生干预越来越多地涉及多个合作伙伴和生态层面.
- 这些干预措施的复杂性和灵活性挑战了传统的评估方法.
- 需要实践指导,以建立评估复杂公共卫生倡议的能力.
研究的目的:
- 描述定性FIND (框架,识别,狭窄,做) 评估过程.
- 为评估复杂,社区参与的健康公平干预提供实际指导.
- 用例子和工具来说明FIND流程的应用.
主要方法:
- FIND流程是一种对复杂性敏感的定性评估方法.
- 在项目团队中嵌入了一个评估人员,以便实时收集数据并进行交互.
- 该过程涉及制定灵活的框架,识别和缩小具有影响力的事件,并根据数据做出明智的决策.
主要成果:
- 在FIND过程中,可以更容易地识别出传统方法可能错过的重大项目事件.
- 将评估员纳入项目团队对于理解和利用现场发展至关重要.
- 该方法支持持续收集数据,以指导干预实施.
结论:
- FIND流程是评估复杂,社区参与的健康公平干预措施的宝贵工具.
- 嵌入式评估器可以增强对实时实施数据的理解和利用.
- 需要进一步的指导,以建立复杂干预评估和利益相关者沟通的能力.
相关概念视频
01:17Cochran's Q Test
229
Cochran's Q Test is a nonparametric statistical test used to determine if there are potential differences in the outcomes of three or more related groups on a binary (yes/no) or dichotomous outcome. It is essentially an extension of the McNemar Test, which is limited to two related samples - Cochran's Q test can handle three or more related samples, making it more versatile in scenarios where subjects are measured under multiple conditions. The test statistic follows a Chi-Square...
229
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121
01:15Nursing Evaluation
3.2K
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
3.2K
01:20Study Designs in Epidemiology
182
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
182
01:25Strategies for Assessing and Addressing Confounding
83
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
83
01:12Hazard Ratio
91
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
91